Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients - a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes.
The MicroShunt effectively and safely lowered intraocular pressure and medication burden for up to six years in open-angle glaucoma patients, with outcomes consistent across combined and standalone procedures, supporting its real-world clinical reliability.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026 Mar 28 glaucoma-surgery